Original Research
Published on 17 May 2019
Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy
in Respiratory Pharmacology
- 4,904 views
- 23 citations
Original Research
Published on 17 May 2019
in Respiratory Pharmacology
Mini Review
Published on 09 May 2019
in Respiratory Pharmacology
Original Research
Published on 25 Apr 2019
in Respiratory Pharmacology
Original Research
Published on 05 Apr 2019
in Respiratory Pharmacology
Review
Published on 29 Mar 2019
in Respiratory Pharmacology
Mini Review
Published on 28 Mar 2019
in Respiratory Pharmacology
Original Research
Published on 22 Mar 2019
in Respiratory Pharmacology
Original Research
Published on 20 Mar 2019
in Respiratory Pharmacology
Original Research
Published on 15 Mar 2019
in Respiratory Pharmacology
Original Research
Published on 12 Mar 2019
in Respiratory Pharmacology
Original Research
Published on 27 Feb 2019
in Respiratory Pharmacology
Original Research
Published on 26 Feb 2019
in Respiratory Pharmacology
Original Research
Published on 26 Feb 2019
in Respiratory Pharmacology
Original Research
Published on 14 Feb 2019
in Respiratory Pharmacology
Original Research
Published on 13 Feb 2019
in Respiratory Pharmacology
Original Research
Published on 12 Feb 2019
in Respiratory Pharmacology